Resultats globals: 2 registres trobats en 0.03 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
12 p, 843.6 KB Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy / Zhang, Xuanye (Sun Yat-sen University Cancer Center) ; Tian, Dan (Guangdong Academy of Medical Sciences) ; Chen, Yue (The Eighth Affiliated Hospital of Sun Yat-sen University) ; Chen, Chen (Sun Yat-sen University Cancer Center) ; He, Li-Na (Sun Yat-sen University Cancer Center) ; Zhou, Yixin (Sun Yat-sen University Cancer Center) ; Li, Haifeng (Sun Yat-sen University Cancer Center) ; Lin, Zuan (Sun Yat-sen University Cancer Center) ; Chen, Tao (Sun Yat-sen University Cancer Center) ; Wang, Yuhong (Sun Yat-sen University Cancer Center) ; Russo, Alessandro (A.O. Papardo) ; Nadal, Ernest (Hospital Universitari de Bellvitge) ; Passiglia, Francesco (S. Luigi Gonzaga Hospital) ; Soo, Ross Andrew (National University Health System) ; Watanabe, Satoshi (Niigata University Graduate School of Medical and Dental Sciences) ; Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Oh, In-Jae (Hwasun Hospital) ; Fu, Sha (Sun Yat-sen University) ; Hong, Shaodong (Sun Yat-sen University Cancer Center) ; Zhang, Li (Sun Yat-sen University Cancer Center) ; Universitat Autònoma de Barcelona
The aim of this study was to evaluate the safety and survival outcomes of anti-programmed cell death (PD)-1/programmed cell death-ligand 1 (PD-L1) monotherapy in patients with advanced non-small cell lung cancer (NSCLC) and different hepatitis B virus (HBV) infection status. [...]
2021 - 10.21037/tlcr-21-455
Translational Lung Cancer Research, Vol. 10 (july 2021) , p. 3191-3202  
2.
10 p, 361.1 KB Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain) / Corral, Julieta (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ; Espinàs, Josep Alfons (Institut d'Investigació Biomèdica de Bellvitge) ; Cots Reguant, Francesc (Parc de Salut MAR de Barcelona) ; Pareja, Laura (Institut d'Investigació Biomèdica de Bellvitge) ; Solà, Judit (Institut d'Investigació Biomèdica de Bellvitge) ; Font, Rebeca (Institut d'Investigació Biomèdica de Bellvitge) ; Borras, Josep M (Universitat de Barcelona. Departament de Ciències Clíniques)
Assessing of the costs of treating disease is necessary to demonstrate cost-effectiveness and to estimate the budget impact of new interventions and therapeutic innovations. However, there are few comprehensive studies on resource use and costs associated with lung cancer patients in clinical practice in Spain or internationally. [...]
2015 - 10.1186/s12913-015-0725-3
BMC health services research, Vol. 15 (february 2015)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.